US Patent Issued to Anwita Biosciences on Aug. 26 for "Cytokine fusion proteins, and their pharmaceutical compositions and therapeutic applications" (California Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,188, issued on Aug. 26, was assigned to Anwita Biosciences Inc. (San Carlos, Calif.).

"Cytokine fusion proteins, and their pharmaceutical compositions and therapeutic applications" was invented by Ziyang Zhong (Belmont, Calif.), Fan Ye (Mountain View, Calif.), Matthew Siegel (Menlo Park, Calif.) and Jianing Huang (San Mateo, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are a fusion protein comprising first and second cytokine domains, and a half-life extension domain; and a pharmaceutical composition thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a pro...